[
  {
    "id": "aemt-dex-q-001",
    "scope": ["AEMT"],
    "medicationId": "aemt-dex-001",
    "medication": "Dextrose",
    "questionType": "multiple-choice",
    "stem": "Which blood glucose value indicates the need for IV dextrose?",
    "choices": [
      "110 mg/dL",
      "85 mg/dL",
      "58 mg/dL",
      "140 mg/dL"
    ],
    "correctAnswer": "58 mg/dL",
    "rationale": "Hypoglycemia requires rapid glucose correction.",
    "clinicalPearl": "Always confirm hypoglycemia when possible."
  },
  {
    "id": "aemt-dex-q-002",
    "scope": ["AEMT"],
    "medicationId": "aemt-dex-001",
    "medication": "Dextrose",
    "questionType": "multiple-choice",
    "stem": "Why is D10 often preferred over D50 in pediatric patients?",
    "choices": [
      "Longer shelf life",
      "Lower risk of extravasation injury",
      "Faster onset",
      "Less need for IV access"
    ],
    "correctAnswer": "Lower risk of extravasation injury",
    "rationale": "Lower concentration reduces tissue damage risk.",
    "clinicalPearl": "Hypertonic solutions can cause severe tissue necrosis."
  },
  {
    "id": "aemt-dex-q-003",
    "scope": ["AEMT"],
    "medicationId": "aemt-dex-001",
    "medication": "Dextrose",
    "questionType": "multiple-choice",
    "stem": "Which assessment is most important after dextrose administration?",
    "choices": [
      "Heart rate",
      "Blood glucose reassessment",
      "Blood pressure",
      "Skin temperature"
    ],
    "correctAnswer": "Blood glucose reassessment",
    "rationale": "Treatment effectiveness must be confirmed.",
    "clinicalPearl": "Treat, reassess, and prevent recurrence."
  },

  {
    "id": "aemt-nalox-q-001",
    "scope": ["AEMT"],
    "medicationId": "aemt-nalox-001",
    "medication": "Naloxone",
    "questionType": "multiple-choice",
    "stem": "Naloxone administration primarily improves which patient condition?",
    "choices": [
      "Hypotension",
      "Respiratory depression",
      "Chest pain",
      "Hypoglycemia"
    ],
    "correctAnswer": "Respiratory depression",
    "rationale": "Naloxone reverses opioid-induced respiratory depression.",
    "clinicalPearl": "Airway and ventilation always come first."
  },
  {
    "id": "aemt-nalox-q-002",
    "scope": ["AEMT"],
    "medicationId": "aemt-nalox-001",
    "medication": "Naloxone",
    "questionType": "multiple-choice",
    "stem": "Which response is most likely after naloxone administration?",
    "choices": [
      "Gradual sedation",
      "Improved respirations with agitation",
      "Immediate pain relief",
      "Decreased heart rate"
    ],
    "correctAnswer": "Improved respirations with agitation",
    "rationale": "Rapid opioid reversal may cause acute withdrawal.",
    "clinicalPearl": "Expect agitation—protect yourself and the patient."
  },
  {
    "id": "aemt-nalox-q-003",
    "scope": ["AEMT"],
    "medicationId": "aemt-nalox-001",
    "medication": "Naloxone",
    "questionType": "multiple-choice",
    "stem": "Why must patients receiving naloxone be closely monitored?",
    "choices": [
      "Naloxone causes hypoglycemia",
      "Naloxone has a shorter duration than many opioids",
      "Naloxone causes bradycardia",
      "Naloxone permanently blocks opioid receptors"
    ],
    "correctAnswer": "Naloxone has a shorter duration than many opioids",
    "rationale": "Re-narcotization can occur after naloxone wears off.",
    "clinicalPearl": "Repeat dosing may be required."
  },
  {
    "id": "aemt-dex-q-001",
    "scope": ["AEMT"],
    "medicationId": "aemt-dex-001",
    "medication": "Dextrose",
    "questionType": "multiple-choice",
    "stem": "Which blood glucose value indicates the need for IV dextrose?",
    "choices": [
      "110 mg/dL",
      "85 mg/dL",
      "58 mg/dL",
      "140 mg/dL"
    ],
    "correctAnswer": "58 mg/dL",
    "rationale": "Hypoglycemia requires rapid glucose correction.",
    "clinicalPearl": "Always confirm hypoglycemia when possible."
  },
  {
    "id": "aemt-dex-q-002",
    "scope": ["AEMT"],
    "medicationId": "aemt-dex-001",
    "medication": "Dextrose",
    "questionType": "multiple-choice",
    "stem": "Why is D10 often preferred over D50 in pediatric patients?",
    "choices": [
      "Longer shelf life",
      "Lower risk of extravasation injury",
      "Faster onset",
      "Less need for IV access"
    ],
    "correctAnswer": "Lower risk of extravasation injury",
    "rationale": "Lower concentration reduces tissue damage risk.",
    "clinicalPearl": "Hypertonic solutions can cause severe tissue necrosis."
  },
  {
    "id": "aemt-dex-q-003",
    "scope": ["AEMT"],
    "medicationId": "aemt-dex-001",
    "medication": "Dextrose",
    "questionType": "multiple-choice",
    "stem": "Which assessment is most important after dextrose administration?",
    "choices": [
      "Heart rate",
      "Blood glucose reassessment",
      "Blood pressure",
      "Skin temperature"
    ],
    "correctAnswer": "Blood glucose reassessment",
    "rationale": "Treatment effectiveness must be confirmed.",
    "clinicalPearl": "Treat, reassess, and prevent recurrence."
  },
  {
    "id": "aemt-nalox-q-001",
    "scope": ["AEMT"],
    "medicationId": "aemt-nalox-001",
    "medication": "Naloxone",
    "questionType": "multiple-choice",
    "stem": "Naloxone administration primarily improves which patient condition?",
    "choices": [
      "Hypotension",
      "Respiratory depression",
      "Chest pain",
      "Hypoglycemia"
    ],
    "correctAnswer": "Respiratory depression",
    "rationale": "Naloxone reverses opioid-induced respiratory depression.",
    "clinicalPearl": "Airway and ventilation always come first."
  },
  {
    "id": "aemt-nalox-q-002",
    "scope": ["AEMT"],
    "medicationId": "aemt-nalox-001",
    "medication": "Naloxone",
    "questionType": "multiple-choice",
    "stem": "Which response is most likely after naloxone administration?",
    "choices": [
      "Gradual sedation",
      "Improved respirations with agitation",
      "Immediate pain relief",
      "Decreased heart rate"
    ],
    "correctAnswer": "Improved respirations with agitation",
    "rationale": "Rapid opioid reversal may cause acute withdrawal.",
    "clinicalPearl": "Expect agitation—protect yourself and the patient."
  },
  {
    "id": "aemt-nalox-q-003",
    "scope": ["AEMT"],
    "medicationId": "aemt-nalox-001",
    "medication": "Naloxone",
    "questionType": "multiple-choice",
    "stem": "Why must patients receiving naloxone be closely monitored?",
    "choices": [
      "Naloxone causes hypoglycemia",
      "Naloxone has a shorter duration than many opioids",
      "Naloxone causes bradycardia",
      "Naloxone permanently blocks opioid receptors"
    ],
    "correctAnswer": "Naloxone has a shorter duration than many opioids",
    "rationale": "Re-narcotization can occur after naloxone wears off.",
    "clinicalPearl": "Repeat dosing may be required."
  },
  {
    "id": "aemt-ns-q-001",
    "scope": ["AEMT"],
    "medicationId": "aemt-ns-001",
    "medication": "Normal Saline",
    "questionType": "multiple-choice",
    "stem": "Normal saline improves perfusion primarily through which mechanism?",
    "choices": [
      "Increasing cardiac contractility",
      "Expanding intravascular volume",
      "Causing vasodilation",
      "Reducing afterload"
    ],
    "correctAnswer": "Expanding intravascular volume",
    "rationale": "Normal saline increases circulating volume, improving preload and perfusion.",
    "clinicalPearl": "Crystalloids restore volume but do not carry oxygen."
  },
  {
    "id": "aemt-ns-q-002",
    "scope": ["AEMT"],
    "medicationId": "aemt-ns-001",
    "medication": "Normal Saline",
    "questionType": "multiple-choice",
    "stem": "Which patient is at greatest risk for complications from large-volume normal saline boluses?",
    "choices": [
      "Young trauma patient",
      "Patient with heart failure",
      "Dehydrated athlete",
      "Febrile pediatric patient"
    ],
    "correctAnswer": "Patient with heart failure",
    "rationale": "Fluid overload can worsen pulmonary edema in heart failure.",
    "clinicalPearl": "Always reassess lung sounds during fluid resuscitation."
  },
  {
    "id": "aemt-ns-q-003",
    "scope": ["AEMT"],
    "medicationId": "aemt-ns-001",
    "medication": "Normal Saline",
    "questionType": "multiple-choice",
    "stem": "What is the standard initial adult bolus dose of normal saline for hypovolemia?",
    "choices": [
      "100–250 mL",
      "250–500 mL",
      "500–1000 mL",
      "1500–2000 mL"
    ],
    "correctAnswer": "500–1000 mL",
    "rationale": "Initial adult fluid boluses are typically 500–1000 mL per protocol.",
    "clinicalPearl": "Bolus, reassess, repeat if indicated."
  },

  {
    "id": "aemt-apap-q-001",
    "scope": ["AEMT"],
    "medicationId": "aemt-apap-001",
    "medication": "Acetaminophen",
    "questionType": "multiple-choice",
    "stem": "Acetaminophen reduces fever primarily by acting where?",
    "choices": [
      "Peripheral nerves",
      "Hypothalamus",
      "Platelets",
      "Adrenal cortex"
    ],
    "correctAnswer": "Hypothalamus",
    "rationale": "Acetaminophen acts centrally to reduce the hypothalamic set point.",
    "clinicalPearl": "It is not an anti-inflammatory medication."
  },
  {
    "id": "aemt-apap-q-002",
    "scope": ["AEMT"],
    "medicationId": "aemt-apap-001",
    "medication": "Acetaminophen",
    "questionType": "multiple-choice",
    "stem": "Which condition contraindicates acetaminophen use?",
    "choices": [
      "Renal disease",
      "Peptic ulcer disease",
      "Severe liver disease",
      "Hypertension"
    ],
    "correctAnswer": "Severe liver disease",
    "rationale": "Acetaminophen is hepatotoxic at high doses or in liver disease.",
    "clinicalPearl": "Always consider cumulative daily dose."
  },
  {
    "id": "aemt-apap-q-003",
    "scope": ["AEMT"],
    "medicationId": "aemt-apap-001",
    "medication": "Acetaminophen",
    "questionType": "multiple-choice",
    "stem": "Which is an appropriate pediatric dose of acetaminophen?",
    "choices": [
      "5 mg/kg",
      "10–15 mg/kg",
      "25 mg/kg",
      "50 mg/kg"
    ],
    "correctAnswer": "10–15 mg/kg",
    "rationale": "Standard pediatric dosing is weight based at 10–15 mg/kg.",
    "clinicalPearl": "Weight-based dosing prevents toxicity."
  },

  {
    "id": "aemt-ibu-q-001",
    "scope": ["AEMT"],
    "medicationId": "aemt-ibu-001",
    "medication": "Ibuprofen",
    "questionType": "multiple-choice",
    "stem": "Ibuprofen reduces pain primarily by inhibiting which enzyme?",
    "choices": [
      "Lipoxygenase",
      "Cyclooxygenase",
      "Acetylcholinesterase",
      "Monoamine oxidase"
    ],
    "correctAnswer": "Cyclooxygenase",
    "rationale": "COX inhibition decreases prostaglandin production.",
    "clinicalPearl": "Prostaglandins mediate pain, fever, and inflammation."
  },
  {
    "id": "aemt-ibu-q-002",
    "scope": ["AEMT"],
    "medicationId": "aemt-ibu-001",
    "medication": "Ibuprofen",
    "questionType": "multiple-choice",
    "stem": "Which patient should NOT receive ibuprofen?",
    "choices": [
      "Fever with dehydration",
      "History of renal disease",
      "Musculoskeletal injury",
      "Mild headache"
    ],
    "correctAnswer": "History of renal disease",
    "rationale": "NSAIDs can worsen renal perfusion.",
    "clinicalPearl": "NSAIDs affect renal blood flow."
  },
  {
    "id": "aemt-ibu-q-003",
    "scope": ["AEMT"],
    "medicationId": "aemt-ibu-001",
    "medication": "Ibuprofen",
    "questionType": "multiple-choice",
    "stem": "What is a common adverse effect of ibuprofen?",
    "choices": [
      "Hypoglycemia",
      "GI irritation",
      "Bradycardia",
      "Respiratory depression"
    ],
    "correctAnswer": "GI irritation",
    "rationale": "NSAIDs increase gastric irritation and bleeding risk.",
    "clinicalPearl": "Consider GI history before NSAID use."
  },

  {
    "id": "aemt-char-q-001",
    "scope": ["AEMT"],
    "medicationId": "aemt-char-001",
    "medication": "Activated Charcoal",
    "questionType": "multiple-choice",
    "stem": "Activated charcoal works by which mechanism?",
    "choices": [
      "Neutralizing stomach acid",
      "Binding toxins in the GI tract",
      "Inducing emesis",
      "Increasing renal excretion"
    ],
    "correctAnswer": "Binding toxins in the GI tract",
    "rationale": "Charcoal adsorbs toxins, limiting absorption.",
    "clinicalPearl": "It does not work on all poisons."
  },
  {
    "id": "aemt-char-q-002",
    "scope": ["AEMT"],
    "medicationId": "aemt-char-001",
    "medication": "Activated Charcoal",
    "questionType": "multiple-choice",
    "stem": "Which ingestion is a contraindication to activated charcoal?",
    "choices": [
      "Acetaminophen",
      "Tricyclic antidepressants",
      "Caustic substances",
      "Aspirin"
    ],
    "correctAnswer": "Caustic substances",
    "rationale": "Charcoal does not bind caustics and increases aspiration risk.",
    "clinicalPearl": "Never give charcoal without airway protection."
  },
  {
    "id": "aemt-char-q-003",
    "scope": ["AEMT"],
    "medicationId": "aemt-char-001",
    "medication": "Activated Charcoal",
    "questionType": "multiple-choice",
    "stem": "Which patient must NOT receive activated charcoal?",
    "choices": [
      "Alert adult",
      "Patient with intact gag reflex",
      "Patient with decreased LOC",
      "Cooperative pediatric patient"
    ],
    "correctAnswer": "Patient with decreased LOC",
    "rationale": "Aspiration risk is high without airway protection.",
    "clinicalPearl": "Airway comes before antidotes."
  },

  {
    "id": "aemt-duoneb-q-001",
    "scope": ["AEMT"],
    "medicationId": "aemt-duoneb-001",
    "medication": "Albuterol / Ipratropium (DuoNeb)",
    "questionType": "multiple-choice",
    "stem": "DuoNeb combines which two pharmacologic actions?",
    "choices": [
      "Alpha agonist and steroid",
      "Beta-2 agonist and anticholinergic",
      "Steroid and antihistamine",
      "Beta blocker and bronchodilator"
    ],
    "correctAnswer": "Beta-2 agonist and anticholinergic",
    "rationale": "Albuterol and ipratropium provide dual bronchodilation.",
    "clinicalPearl": "Combination therapy improves airflow."
  },
  {
    "id": "aemt-duoneb-q-002",
    "scope": ["AEMT"],
    "medicationId": "aemt-duoneb-001",
    "medication": "Albuterol / Ipratropium (DuoNeb)",
    "questionType": "multiple-choice",
    "stem": "Which patient would benefit most from DuoNeb?",
    "choices": [
      "Pulmonary edema",
      "CHF exacerbation",
      "COPD exacerbation",
      "Pneumothorax"
    ],
    "correctAnswer": "COPD exacerbation",
    "rationale": "Combination bronchodilators are first-line in COPD flares.",
    "clinicalPearl": "COPD often requires dual therapy."
  },
  {
    "id": "aemt-duoneb-q-003",
    "scope": ["AEMT"],
    "medicationId": "aemt-duoneb-001",
    "medication": "Albuterol / Ipratropium (DuoNeb)",
    "questionType": "multiple-choice",
    "stem": "Which side effect is most associated with albuterol?",
    "choices": [
      "Bradycardia",
      "Tremors and tachycardia",
      "Respiratory depression",
      "Hypotension"
    ],
    "correctAnswer": "Tremors and tachycardia",
    "rationale": "Beta-2 stimulation commonly causes tremors and tachycardia.",
    "clinicalPearl": "Monitor heart rate during repeated treatments."
  }
]

